BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho YK, Shin EY, Uehara H, Ambati BK. Effect of sorafenib in a murine high risk penetrating keratoplasty model. Int J Ophthalmol 2017;10:834-9. [PMID: 28730071 DOI: 10.18240/ijo.2017.06.02] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Yamakawa M, Doh SJ, Santosa SM, Montana M, Qin EC, Kong H, Han KY, Yu C, Rosenblatt MI, Kazlauskas A, Chang JH, Azar DT. Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. Med Res Rev 2018;38:1769-98. [PMID: 29528507 DOI: 10.1002/med.21496] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
2 Armitage WJ, Goodchild C, Griffin MD, Gunn DJ, Hjortdal J, Lohan P, Murphy CC, Pleyer U, Ritter T, Tole DM, Vabres B. High-risk Corneal Transplantation: Recent Developments and Future Possibilities. Transplantation 2019;103:2468-78. [PMID: 31765363 DOI: 10.1097/TP.0000000000002938] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]